Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Cutaneous (Skin) Cancer Clinical Research and Trials

  • The Center for Cutaneous Oncology has been associated with the National Cancer Institute-supported Specialized Program of Research Excellence (SPORE) since 2001. The Harvard Skin Cancer SPORE is the first of its kind in the U.S. designed to speed laboratory insights directly to patient care. Many of our physicians who treat patients with skin cancer are involved in the research associated with the SPORE grant.

    Clinical trials

    The Center for Cutaneous Oncology has a variety of clinical trials available. You can enroll in our blood, tissue, and database collection studies for cutaneous T cell lymphoma (CTCL) or Merkel cell carcinoma (MCC). The goal of this research is to understand the genetic and biologic factors that may contribute to the development of CTCL and MCC, and to better understand why tumors develop.

    The Center for Cutaneous Oncology has a variety of targeted therapeutic clinical trials for the treatment of CTCL, MCC and basal cell carcinoma (BCC).

    For more information regarding enrollment and eligibility, please call 617-632-6571.

  • New Patient Appointments

    Make Appointment Online
    Dana-Farber Brigham Cancer Center logo
    US News adult badge - smaller

  • Clinical Trials Questions?